Quick answers
- What is Wynzora?
- Wynzora is a brand name of Calcipotriene and betamethasone dipropionate (betamethasone dipropionate / calcipotriene), a prescription medicine. The FDA NDC Directory lists 1 Wynzora product in 1 strength and form.
- Who makes Wynzora?
- MC2 holds the FDA application for Wynzora (NDA213422, approved July 20, 2020).
- Is there a generic or store brand of Wynzora?
- Other products of Calcipotriene and betamethasone dipropionate (betamethasone dipropionate / calcipotriene) are listed with the FDA, but none in exactly the same strength and form as a Wynzora product.
- Has Wynzora been recalled?
- No recall linked to Wynzora products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Wynzora is
Each Wynzora product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Calcipotriene and betamethasone dipropionate (betamethasone dipropionate / calcipotriene) · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| betamethasone dipropionate 6.4% · calcipotriene 50 ug/g cream (topical) | Wynzora | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Calcipotriene and betamethasone dipropionate (betamethasone dipropionate / calcipotriene) →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA213422 | MC2 | July 20, 2020 | 1 |
Companies that list Wynzora
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Wynzora products.
- MC2 Therapeutics Ltd1 product
Recalls
No recall linked to Wynzora products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.